Belgium· BE-AMP-SAM251903-00

Hepsera 10 mg

A adefovir dipivoxil product containing adefovir dipivoxil, registered in Belgium by Gilead Sciences Ireland UC. The same ATC class is registered in 4 of our 19 countries.

ATC J05AF08

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedHepsera 10 mgATCJ05AF08REGISTER NO.BE-AMP-SAM251903-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Adefovir dipivoxil is registered in 4 of 19 countries.

Countries holding a registration under ATC J05AF08 (adefovir dipivoxil), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 4 of them publish a price we can compare per daily dose

Adefovir dipivoxil · ATC J05AF08

4 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Franceprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of adefovir dipivoxil costs, country by country.

Normalised to the WHO defined daily dose (10 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Adefovir dipivoxil · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • FR France$18.59
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Adefovir Dipivoxil
Manufacturer
Gilead Sciences Ireland UC
Country
Belgium (BE)
ATC code
J05AF08
ATC class
Adefovir dipivoxil
Defined daily dose
10 mg, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    0775932
  • be_apb
    1784032

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

33 interactions on record for adefovir dipivoxil.

Graded by severity as the source publishes them — 33 info. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Adefovir dipivoxil · interactions on record

33 records

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Adefovir dipivoxil in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All adefovir dipivoxil products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/86f9bd55-091f-4400-87d0-db349fcb70a2
GET /v1/drugs/86f9bd55-091f-4400-87d0-db349fcb70a2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Hepsera 10 mg",
  "name_fr": "Hepsera 10 mg",
  "name_nl": "Hepsera 10 mg",
  "amp_code": "SAM251903-00",
  "strengths": [
    "10.0000",
    "10.0000",
    "10.0000",
    "113.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Adefovir Dipivoxil",
    "Lactose Monohydrate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Adefovir Dipivoxil",
  "authorisation_numbers": [
    "EU/1/03/251/001",
    "EU/1/03/251/002"
  ]
}

See everything about adefovir dipivoxil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.